Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CF BANKSHARES INC. (CFBK)
|
Add to portfolio |
|
|
|
| Price: |
$19.75
| | Metrics |
| OS: |
6.55
|
M
| |
12
|
% ROE
|
| Market cap: |
$129
|
M
| |
109
|
% ROIC
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
$2.70
| |
7.3
|
x P/E
|
|
BVPS
|
$22.50
| |
0.88
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 89.9 | 74.3 | 117.0 | 60.2 | 20.6 | 14.4 | 12.3 | 10.9 |
| Revenue growth | 21.1% | -36.5% | 94.2% | 192.3% | 42.9% | 17.6% | 12.5% | 9.7% |
| Cost of goods sold | 16.4 | 18.1 | 23.1 | 12.1 | 9.3 | 7.1 | 5.9 | 5.6 |
| Gross profit | 73.6 | 56.2 | 93.9 | 48.1 | 11.3 | 7.3 | 6.4 | 5.3 |
| Gross margin | 81.8% | 75.7% | 80.3% | 79.9% | 54.7% | 50.7% | 51.9% | 48.6% |
| Sales and marketing | | | | | 1.4 | 0.2 | 0.1 | 0.1 |
| General and administrative | 3.2 | 2.5 | 2.2 | 1.8 | 2.6 | 2.3 | 2.6 | 2.3 |
| EBITA | 71.6 | 59.7 | 150.0 | 56.8 | 8.9 | 4.7 | 3.5 | 3.9 |
| EBITA margin | 79.6% | 80.3% | 128.2% | 94.3% | 43.2% | 32.9% | 28.3% | 35.8% |
| Amortization of intangibles | 0.6 | | | | | | | |
| EBIT | 71.0 | 59.7 | 150.0 | 56.8 | 8.9 | 4.7 | 3.5 | 3.9 |
| EBIT margin | 78.9% | 80.3% | 128.2% | 94.3% | 43.2% | 32.9% | 28.3% | 35.8% |
| Pre-tax income | 22.6 | 22.8 | 36.3 | 12.0 | 5.3 | 3.5 | 2.4 | 1.3 |
| Income taxes | 4.4 | 4.4 | 6.7 | 2.4 | 1.1 | 2.1 | 0.8 | -3.2 |
| Tax rate | 19.6% | 19.1% | 18.4% | 20.3% | 19.8% | 61.1% | 33.2% | |
| Net income | 18.2 | 18.5 | 29.6 | 9.6 | 4.3 | 0.7 | 0.8 | 3.6 |
| Net margin | 20.2% | 24.8% | 25.3% | 15.9% | 20.7% | 4.7% | 6.3% | 33.2% |
| |
| Diluted EPS | $2.78 | $2.77 | $4.85 | $2.07 | $0.98 | $0.19 | $0.05 | $0.16 |
| Shares outstanding (diluted) | 6.5 | 6.7 | 6.1 | 4.6 | 4.3 | 3.5 | 16.1 | 22.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|